Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.620
+0.320 (7.44%)
At close: Nov 19, 2025, 4:00 PM EST
4.620
0.00 (0.00%)
After-hours: Nov 19, 2025, 4:00 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $39.75 million as of November 19, 2025. Its market cap has increased by 14.89% in one year.
Market Cap
39.75M
Enterprise Value
19.59M
1-Year Change
14.89%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $39.75M, a decrease of -45.43%. That is a compound annual growth rate of -14.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 39.53M | 21.34% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |